Strategies to functionalize extracellular vesicles against HER2 for anticancer activity
2022

Functionalizing Extracellular Vesicles for Cancer Treatment

publication Evidence: moderate

Author Information

Author(s): Gurrieri Elena, D’Agostino Vito Giuseppe

Primary Institution: University of Trento

Hypothesis

Can extracellular vesicles be effectively functionalized to target HER2 for anticancer activity?

Conclusion

Extracellular vesicles can be engineered to target HER2, showing promise for enhanced cancer therapy.

Supporting Evidence

  • Extracellular vesicles are stable and can deliver therapeutic agents effectively.
  • HER2 is a clinically relevant target for cancer therapy.
  • Different strategies exist for functionalizing extracellular vesicles to enhance targeting.

Takeaway

Scientists are figuring out how to make tiny bubbles from cells that can deliver medicine directly to cancer cells, helping to treat the disease better.

Methodology

The review summarizes various strategies for engineering extracellular vesicles to target HER2, including manipulating donor cells and post-isolation modifications.

Limitations

The review does not provide comparative relationships based on the yield of specific EV sub-populations or their stability.

Digital Object Identifier (DOI)

10.20517/evcna.2022.07

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication